小児脳腫瘍の世界市場レポート 2025年

小児脳腫瘍の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.1％で18億3,000万米ドルに成長します。この予測期間における成長は、精密医療、分子プロファイリング、標的治療、ヘルスケアインフラの向上、保険適用範囲の拡大などの進歩に起因しています。主な動向としては、磁気共鳴画像法（MRI）、陽電子放射断層撮影法（PET）、コンピュータ断層撮影法（CT）スキャン技術の向上、遺伝子・分子プロファイリングの利用拡大、標的療法の開発、免疫療法の導入、低侵襲手術技術の台頭などが挙げられます。

個別化医療に対する需要の高まりは、小児脳腫瘍市場の成長を促進すると予想されます。個別化医療とは、個人の遺伝子プロファイル、ライフスタイル、特定の健康ニーズに合わせて治療や医療上の決定を行うヘルスケアアプローチです。個別化医療の需要は、遺伝子研究の進歩、診断ツールの改善、より正確で効果的な治療の可能性により高まっています。子どもの腫瘍の種類、遺伝子変異、反応パターンに基づいて治療をカスタマイズすることで、個別化医療は治療成果を高めると同時に、健康な組織へのダメージを最小限に抑え、副作用を軽減します。例えば、2024年2月、米国のヘルスケア団体である個別化医療連合（Personalized Medicine Coalition）は、FDAが2023年に希少疾患に対する新たな個別化治療を16件承認し、2022年の6件から増加したと報告しました。その結果、個別化医療に対する需要の高まりが、小児脳腫瘍市場の拡大に拍車をかけています。

小児脳腫瘍市場の各社は、標的治療を改善し患者の予後を改善するために、II型RAF阻害剤などの革新的治療法の開発に注力しています。II型RAF阻害剤は、RAFキナーゼ、特に腫瘍の増殖を促進する変異を持つRAFキナーゼを選択的に阻害することで機能します。これらの阻害剤は、特定の小児低悪性度神経膠腫（pLGG）サブタイプに見られる異常なRAFタンパク質構造を標的とし、腫瘍細胞の増殖と生存に寄与する誤ったシグナル伝達経路を効果的に破壊します。例えば、2024年4月、米国のバイオテクノロジー企業であるDay One Biopharmaceuticals社は、特定のBRAF変化を有する生後6カ月以上の再発または難治性の小児低悪性度神経膠腫（pLGG）の治療薬として、OJEMDA（tovorafenib）が米国食品医薬品局（FDA）から早期承認を取得したと発表しました。今回の承認により、OJEMDAはこの患者群におけるBRAF融合または変異を標的とした初めてのFDA承認治療薬となります。今回の決定は、51％の全奏効率を示したFIREFLY-1臨床試験のデータに基づいており、前治療に反応しなかった小児脳腫瘍に対する本剤の有効性が強調されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界小児脳腫瘍PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の小児脳腫瘍市場：成長率分析
• 世界の小児脳腫瘍市場の実績：規模と成長, 2019-2024
• 世界の小児脳腫瘍市場の予測：規模と成長, 2024-2029, 2034F
• 世界小児脳腫瘍総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の小児脳腫瘍市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経膠腫
• 混合神経グリア腫瘍
• 胎児性腫瘍
• 脈絡叢乳頭腫またはがん
• 非神経上皮組織から発生する腫瘍
• 髄膜腫瘍
• 世界の小児脳腫瘍市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 手術
• 放射線治療
• 化学療法
• 標的療法
• 免疫療法
• 世界の小児脳腫瘍市場診断方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像技術
• 生検
• 神経学的検査
• 腰椎穿刺
• 世界の小児脳腫瘍市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乳児
• 幼児
• 子供たち
• 青少年
• 世界の小児脳腫瘍市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 医療研究センター
• 学術機関
• その他の用途
• 世界の小児脳腫瘍市場神経膠腫の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低悪性度神経膠腫
• 高悪性度神経膠腫
• 世界の小児脳腫瘍市場混合神経グリア腫瘍の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 神経節腫
• 異形成性神経上皮腫瘍（DNET）
• 世界の小児脳腫瘍市場胎児性腫瘍の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 髄芽腫
• 非典型奇形性ラブドイド腫瘍（ATRT）
• 原始的神経外胚葉性腫瘍（PNET）
• 世界の小児脳腫瘍市場脈絡叢乳頭腫またはがんの種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脈絡叢乳頭腫
• 脈絡叢がん
• 世界の小児脳腫瘍市場非神経上皮組織由来の腫瘍の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 横紋筋肉腫
• ユーイング肉腫
• 世界の小児脳腫瘍市場髄膜腫瘍の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 髄膜腫
• 血管周皮腫

第7章 地域別・国別分析

• 世界の小児脳腫瘍市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の小児脳腫瘍市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 小児脳腫瘍市場：競合情勢
• 小児脳腫瘍市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• UCLA Health
• Ipsen Pharma
• Novocure
• Blueprint Medicines
• Karyopharm Therapeutics Inc.
• Renaissance Pharma
• Servier Laboratories
• Matica Biotechnology
• Curis Inc.
• Oncoheroes Biosciences
• Treovir Inc.
• Plus Therapeutics Inc.
• Stemline Therapeutics Inc.
• BrainChild Bio Inc.
• Seattle Children's Therapeutics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 小児脳腫瘍市場2029：新たな機会を提供する国
• 小児脳腫瘍市場2029：新たな機会を提供するセグメント
• 小児脳腫瘍市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pediatric brain tumors are abnormal cell growths in the brain or central nervous system (CNS) of children, which can be either benign (non-cancerous) or malignant (cancerous). These tumors may develop in different areas of the brain or spinal cord, with treatment aimed at shrinking or removing the tumor, alleviating symptoms, and preserving cognitive and motor functions to support the child's long-term health and development.

The primary types of pediatric brain tumors include gliomas, mixed neuronal-glial tumors, embryonal tumors, choroid plexus papilloma or carcinoma, tumors arising from non-neuroepithelial tissue, and meningeal tumors. Gliomas are the most common type, originating from glial cells and requiring aggressive treatment due to their infiltrative growth and high recurrence potential. Treatment options include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy, while diagnostic methods involve imaging techniques, biopsy, neurological exams, and lumbar puncture. Pediatric brain tumors can occur in various age groups, including infants, toddlers, children, and adolescents, and are managed in settings such as hospitals and clinics, medical research centers, academic institutes, and others.

The pediatric brain tumor market research report is one of a series of new reports from The Business Research Company that provides pediatric brain tumor market statistics, including the pediatric brain tumor industry global market size, regional shares, competitors with the pediatric brain tumor market share, detailed pediatric brain tumor market segments, market trends, and opportunities, and any further data you may need to thrive in the pediatric brain tumor industry. This pediatric brain tumor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pediatric brain tumor market size has grown strongly in recent years. It will grow from $1.4 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the increasing incidence of pediatric brain tumors, the rise of emerging economies, growing investment in research and development, the increasing demand for advanced diagnostic technology, and the global rise in pediatric tumor cases.

The pediatric brain tumor market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to the advancements in precision medicine, molecular profiling, targeted therapy, rising healthcare infrastructure, and extended insurance coverage. Major trends include improvements in magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT) scanning technologies, the increasing use of genetic and molecular profiling, the development of targeted therapies, the introduction of immunotherapies, and the rise of minimally invasive surgical techniques.

The increasing demand for personalized medicine is expected to drive growth in the pediatric brain tumors market. Personalized medicine is a healthcare approach that tailors treatments and medical decisions to an individual's genetic profile, lifestyle, and specific health needs. The demand for personalized medicine is rising due to advancements in genetic research, improved diagnostic tools, and the potential for more precise and effective treatments. By customizing therapies based on a child's tumor type, genetic mutations, and response patterns, personalized medicine enhances treatment outcomes while minimizing damage to healthy tissue and reducing side effects. For instance, in February 2024, the Personalized Medicine Coalition, a US-based healthcare organization, reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, up from six in 2022. As a result, the growing demand for personalized medicine is fueling the expansion of the pediatric brain tumor market.

Companies in the pediatric brain tumors market are focusing on developing innovative treatments such as type II RAF inhibitors to improve targeted therapies and enhance patient outcomes. Type II RAF inhibitors work by selectively inhibiting RAF kinases, particularly those with mutations that promote tumor growth. These inhibitors target abnormal RAF protein structures found in certain pediatric low-grade glioma (pLGG) subtypes, effectively disrupting faulty signaling pathways that contribute to tumor cell proliferation and survival. For example, in April 2024, Day One Biopharmaceuticals, a US-based biotechnology company, announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for OJEMDA (tovorafenib) for the treatment of relapsed or refractory pediatric low-grade glioma (pLGG) in patients aged six months and older with specific BRAF alterations. This approval marks OJEMDA as the first FDA-approved therapy targeting BRAF fusions or mutations in this patient group. The decision was based on data from the FIREFLY-1 clinical trial, which demonstrated an overall response rate of 51%, highlighting the drug's efficacy in treating pediatric brain tumors that have not responded to prior treatments.

In July 2024, Ipsen, a France-based biopharmaceutical company, entered into a partnership with Day One Biopharmaceuticals to commercialize tovorafenib for pediatric low-grade glioma (pLGG) outside the United States. Through this collaboration, Ipsen will manage the regulatory and commercial aspects of tovorafenib's global expansion. Day One Biopharmaceuticals, a US-based company specializing in treatments for childhood brain tumors, developed OJEMDA to address the unmet medical needs of pediatric patients.

Major players in the pediatric brain tumors market are AbbVie Inc., Bayer AG, Novartis AG, Roche Holding AG, Takeda Pharmaceutical Company, UCLA Health, Ipsen Pharma, Novocure, Blueprint Medicines, Karyopharm Therapeutics Inc., Renaissance Pharma, Servier Laboratories, Matica Biotechnology, Curis Inc., Oncoheroes Biosciences, Treovir Inc., Plus Therapeutics Inc., Stemline Therapeutics Inc., BrainChild Bio Inc., and Seattle Children's Therapeutics

North America was the largest region in the pediatric brain tumors market in 2024. The regions covered in pediatric brain tumors report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pediatric brain tumors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pediatric brain tumor market consists of revenues earned by entities providing services such as neuro-oncology care, rehabilitation services, psychosocial support, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The pediatric brain tumor market also includes sales of chemotherapy drugs, surgical instruments, and radiation therapy equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric Brain Tumors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pediatric brain tumors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pediatric brain tumors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pediatric brain tumors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Gliomas; Mixed Neuronal-Glial Tumors; Embryonal Tumors; Choroid Plexus Papilloma Or Carcinoma; Tumors Arising From Non-Neuroepithelial Tissue; Meningeal Tumors
• 2) By Treatment Type: Surgery; Radiation Therapy; Chemotherapy; Targeted Therapy; Immunotherapy
• 3) By Diagnosis Method: Imaging Techniques; Biopsy; Neurological Exam; Lumbar Puncture
• 4) By Age Group: Infants; Toddlers; Children; Adolescents
• 5) By Application: Hospitals And Clinics; Medical Research Centers; Academic Institutes; Other Applications
• Subsegments:
• 1) By Gliomas: Low-Grade Gliomas; High-Grade Gliomas
• 2) By Mixed Neuronal-Glial Tumors: Gangliogliomas; Dysembryoplastic Neuroepithelial Tumors (DNET)
• 3) By Embryonal Tumors: Medulloblastoma; Atypical Teratoid Rhabdoid Tumor (ATRT); Primitive Neuroectodermal Tumors (PNET)
• 4) By Choroid Plexus Papilloma or Carcinoma: Choroid Plexus Papilloma; Choroid Plexus Carcinoma
• 5) By Tumors Arising from Non-Neuroepithelial Tissue: Rhabdomyosarcoma; Ewing's Sarcoma
• 6) By Meningeal Tumors: Meningiomas; Hemangiopericytomas
• Companies Mentioned:AbbVie Inc.; Bayer AG; Novartis AG; Roche Holding AG; Takeda Pharmaceutical Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pediatric Brain Tumors Market Characteristics

3. Pediatric Brain Tumors Market Trends And Strategies

4. Pediatric Brain Tumors Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pediatric Brain Tumors Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pediatric Brain Tumors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pediatric Brain Tumors Market Growth Rate Analysis
• 5.4. Global Pediatric Brain Tumors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pediatric Brain Tumors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pediatric Brain Tumors Total Addressable Market (TAM)

6. Pediatric Brain Tumors Market Segmentation

• 6.1. Global Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gliomas
• Mixed Neuronal-Glial Tumors
• Embryonal Tumors
• Choroid Plexus Papilloma Or Carcinoma
• Tumors Arising From Non-Neuroepithelial Tissue
• Meningeal Tumors
• 6.2. Global Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Radiation Therapy
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• 6.3. Global Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Techniques
• Biopsy
• Neurological Exam
• Lumbar Puncture
• 6.4. Global Pediatric Brain Tumors Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infants
• Toddlers
• Children
• Adolescents
• 6.5. Global Pediatric Brain Tumors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Medical Research Centers
• Academic Institutes
• Other Applications
• 6.6. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Gliomas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low-Grade Gliomas
• High-Grade Gliomas
• 6.7. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Mixed Neuronal-Glial Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gangliogliomas
• Dysembryoplastic Neuroepithelial Tumors (DNET)
• 6.8. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Embryonal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medulloblastoma
• Atypical Teratoid Rhabdoid Tumor (ATRT)
• Primitive Neuroectodermal Tumors (PNET)
• 6.9. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Choroid Plexus Papilloma or Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Choroid Plexus Papilloma
• Choroid Plexus Carcinoma
• 6.10. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Tumors Arising from Non-Neuroepithelial Tissue, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rhabdomyosarcoma
• Ewing's Sarcoma
• 6.11. Global Pediatric Brain Tumors Market, Sub-Segmentation Of Meningeal Tumors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Meningiomas
• Hemangiopericytomas

7. Pediatric Brain Tumors Market Regional And Country Analysis

• 7.1. Global Pediatric Brain Tumors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pediatric Brain Tumors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pediatric Brain Tumors Market

• 8.1. Asia-Pacific Pediatric Brain Tumors Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pediatric Brain Tumors Market

• 9.1. China Pediatric Brain Tumors Market Overview
• 9.2. China Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pediatric Brain Tumors Market

• 10.1. India Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pediatric Brain Tumors Market

• 11.1. Japan Pediatric Brain Tumors Market Overview
• 11.2. Japan Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pediatric Brain Tumors Market

• 12.1. Australia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pediatric Brain Tumors Market

• 13.1. Indonesia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pediatric Brain Tumors Market

• 14.1. South Korea Pediatric Brain Tumors Market Overview
• 14.2. South Korea Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pediatric Brain Tumors Market

• 15.1. Western Europe Pediatric Brain Tumors Market Overview
• 15.2. Western Europe Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pediatric Brain Tumors Market

• 16.1. UK Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pediatric Brain Tumors Market

• 17.1. Germany Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pediatric Brain Tumors Market

• 18.1. France Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pediatric Brain Tumors Market

• 19.1. Italy Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pediatric Brain Tumors Market

• 20.1. Spain Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pediatric Brain Tumors Market

• 21.1. Eastern Europe Pediatric Brain Tumors Market Overview
• 21.2. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pediatric Brain Tumors Market

• 22.1. Russia Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pediatric Brain Tumors Market

• 23.1. North America Pediatric Brain Tumors Market Overview
• 23.2. North America Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pediatric Brain Tumors Market

• 24.1. USA Pediatric Brain Tumors Market Overview
• 24.2. USA Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pediatric Brain Tumors Market

• 25.1. Canada Pediatric Brain Tumors Market Overview
• 25.2. Canada Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pediatric Brain Tumors Market

• 26.1. South America Pediatric Brain Tumors Market Overview
• 26.2. South America Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pediatric Brain Tumors Market

• 27.1. Brazil Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pediatric Brain Tumors Market

• 28.1. Middle East Pediatric Brain Tumors Market Overview
• 28.2. Middle East Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pediatric Brain Tumors Market

• 29.1. Africa Pediatric Brain Tumors Market Overview
• 29.2. Africa Pediatric Brain Tumors Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pediatric Brain Tumors Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pediatric Brain Tumors Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pediatric Brain Tumors Market Competitive Landscape And Company Profiles

• 30.1. Pediatric Brain Tumors Market Competitive Landscape
• 30.2. Pediatric Brain Tumors Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Takeda Pharmaceutical Company Overview, Products and Services, Strategy and Financial Analysis

31. Pediatric Brain Tumors Market Other Major And Innovative Companies

• 31.1. UCLA Health
• 31.2. Ipsen Pharma
• 31.3. Novocure
• 31.4. Blueprint Medicines
• 31.5. Karyopharm Therapeutics Inc.
• 31.6. Renaissance Pharma
• 31.7. Servier Laboratories
• 31.8. Matica Biotechnology
• 31.9. Curis Inc.
• 31.10. Oncoheroes Biosciences
• 31.11. Treovir Inc.
• 31.12. Plus Therapeutics Inc.
• 31.13. Stemline Therapeutics Inc.
• 31.14. BrainChild Bio Inc.
• 31.15. Seattle Children's Therapeutics

32. Global Pediatric Brain Tumors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pediatric Brain Tumors Market

34. Recent Developments In The Pediatric Brain Tumors Market

35. Pediatric Brain Tumors Market High Potential Countries, Segments and Strategies

• 35.1 Pediatric Brain Tumors Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pediatric Brain Tumors Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pediatric Brain Tumors Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer